Literature DB >> 9152134

Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity.

B S Shastry1, S D Pendergast, M K Hartzer, X Liu, M T Trese.   

Abstract

BACKGROUND: Retinopathy of prematurity (ROP) is a retinal vascular disease occurring in infants with short gestational age and low birth weight and can lead to retinal detachment (ROP stages 4 and 5). X-linked familial exudative vitreoretinopathy is phenotypically similar to ROP and has been associated with mutations in the Norrie disease (ND) gene in some cases.
OBJECTIVE: To determine if similar mutations in the ND gene may play a role in the development of advanced ROP.
METHODS: Clinical examination and molecular genetic analysis were performed on 16 children, including 2 dizygotic and 1 monozygotic twin pairs, and their parents from 13 families.
RESULTS: Sequencing of the amplified products revealed missense mutations (R121W and L108P) in the third exon of the ND gene in 4 patients. These mutations were not present in an unaffected premature twin, 2 children with regressed stage 3 ROP, the parents, or in 50 unrelated healthy control subjects.
CONCLUSION: These findings suggest that mutations in the ND gene may play a role in the development of severe ROP in premature infants.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152134     DOI: 10.1001/archopht.1997.01100150653015

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  32 in total

1.  Severe retinopathy of prematurity and its association with different rates of survival in infants of less than 1251 g birth weight.

Authors:  J Vyas; D Field; E S Draper; G Woodruff; A R Fielder; J Thompson; N J Shaw; D Clark; R Gregson; J Burke; G Durbin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

Review 2.  Recent advances: ophthalmology.

Authors:  A R Fielder; C Bentley; M J Moseley
Journal:  BMJ       Date:  1999-03-13

Review 3.  Retinopathy of prematurity: recent advances in our understanding.

Authors:  C M Wheatley; J L Dickinson; D A Mackey; J E Craig; M M Sale
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

Review 4.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

Review 5.  Retinopathy of prematurity: recent advances in our understanding.

Authors:  C M Wheatley; J L Dickinson; D A Mackey; J E Craig; M M Sale
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

6.  Novel nonsense mutation (Tyr44stop) of the Norrie disease gene in a Japanese family.

Authors:  Y Hatsukawa; T Nakao; T Yamagishi; N Okamoto; Y Isashiki
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

Review 7.  Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies.

Authors:  Gerd Holmström; Peter van Wijngaarden; Douglas J Coster; Keryn A Williams
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

8.  Lack of association of VEGF (-2578 C-->A) and ANG 2 (-35 G-->C) gene polymorphisms with the progression of retinopathy of prematurity.

Authors:  Barkur S Shastry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-19       Impact factor: 3.117

Review 9.  Genomics in the neonatal nursery: Focus on ROP.

Authors:  Mary Elizabeth Hartnett; C Michael Cotten
Journal:  Semin Perinatol       Date:  2015-10-23       Impact factor: 3.300

10.  Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization.

Authors:  Xin Ye; Yanshu Wang; Hugh Cahill; Minzhong Yu; Tudor C Badea; Philip M Smallwood; Neal S Peachey; Jeremy Nathans
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.